AMBERSTONE
AMBERSTONE is a Pre-seed, Seed, Series A, Series B, Series C+ and early-growth fund in the US writing $100K–$5M checks into food-and-beverage, pet-products, baby-products, personal-care, beauty and wellness.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, early-growth
- Sectors
- food-and-beverage, pet-products, baby-products, personal-care, beauty, wellness
- Check size
- $100K–$5M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $90M
- Website
- amberstone.com
Thesis
Amberstone is a venture capital firm founded in 2019 and headquartered in San Francisco, California. They focus on investing in brand-first consumer product companies that cater to the wellness needs of contemporary and future generations of consumers and families. Their investment thesis centers on identifying disruptive and innovative consumer product companies within the wellness sector, specifically targeting early-growth stage companies with at least $10 million in trailing net sales and strong brand authenticity. Key sectors include food and beverage, pet and baby products, personal care, beauty, and wellness broadly. While they invest across pre-seed, seed, Series A, B, and C rounds, their primary focus is on Series C for US-based startups. Amberstone prefers to lead investment rounds but also collaborates with industry partners. The firm has approximately $90 million in assets under management and typically invests between $100,000 and $5 million, with a sweet spot around $1.5 million per company. They aim to help scale these companies into nationally distributed category leaders.
Common questions
Does AMBERSTONE invest at the Pre-seed stage?
Yes. AMBERSTONE lists Pre-seed, Seed, Series A, Series B, Series C+ and early-growth among the stages it invests in.
What check size does AMBERSTONE write?
AMBERSTONE writes $100K–$5M checks.
Where does AMBERSTONE invest?
AMBERSTONE invests in the US.